Genomics

Dataset Information

0

Chronic p53-independent p21 expression deregulates replication licensing, leading to genomic instability I


ABSTRACT: The cyclin-dependent kinase inhibitor p21WAF1/Cip1 (p21) is a cell-cycle checkpoint effector and inducer of senescence, regulated by p53. Yet, evidence suggests that, through a so-far obscure mechanism, p21 could also be oncogenic. We report that a subset of atypical cancerous cells strongly expressing p21 showed proliferation features. This occurred predominantly in p53-mutant human cancers suggesting p53-independent upregulation of p21 selectively in more aggressive tumour cells. Multifaceted phenotypic and genomic analyses of p21-inducible, p53-null, cancerous and near-normal cellular models showed that after an initial senescence-like phase, a subpopulation of p21-expressing proliferating cells emerged, featuring increased genomic instability, aggressiveness and chemo-resistance. Mechanistically, sustained p21-accumulation inhibited mainly the CRL4CDT2 ubiquitin-ligase, leading to deregulated origin licensing and replication stress. Collectively, our data reveal tumour-promoting ability of p21 through deregulation of DNA replication licensing machinery, an unorthodox role to be considered in cancer treatment, since p21 responds to various stimuli including some chemotherapy drugs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE81752 | GEO | 2016/05/24

SECONDARY ACCESSION(S): PRJNA322499

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-05-24 | GSE81753 | GEO
2016-05-15 | E-GEOD-62166 | biostudies-arrayexpress
2016-05-15 | GSE62166 | GEO
2016-05-17 | PXD004140 | Pride
2010-10-23 | E-GEOD-24760 | biostudies-arrayexpress
2010-10-23 | GSE24760 | GEO
2021-09-07 | PXD022542 | Pride
| PRJNA263336 | ENA
| PRJNA322497 | ENA
2011-01-21 | E-GEOD-24810 | biostudies-arrayexpress